Semax: Complete Research Guide

At a glance: Key facts about Semax research

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH), specifically the ACTH(4-10) fragment modified with a C-terminal Pro-Gly-Pro tripeptide sequence to extend its enzymatic half-life. Preclinical models indicate that Semax alters gene expression associated with neuroplasticity without exhibiting glucocorticoid hormonal activity.

Primary research areas include upregulation of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) signaling, modulation of cerebral blood flow, and neuroprotective responses during ischemic conditions. Investigators evaluate both lyophilized powder reconstituted for parenteral assays and specialized intranasal liquid preparations.

To maintain valid experimental controls, researchers require analytical verification of peptide purity. Researchers can order 10 mg vials of Semax directly from PX1 Research, supported by independent third-party high-performance liquid chromatography (HPLC) and mass spectrometry (MS) reports.

What is Semax? Molecular structure and chemical background

Semax (sequence: Met-Glu-His-Phe-Pro-Gly-Pro) was originally developed as a metabolically stable analog of ACTH(4-10). Natural ACTH fragments demonstrate distinct neurotropic activities in central nervous system models but suffer from rapid enzymatic degradation by circulating peptidases. By appending the C-terminal tripeptide Pro-Gly-Pro (PGP), researchers created a structure resistant to exopeptidase cleavage.

This structural modification significantly extends the biological activity profile of the compound in cellular and animal models without triggering peripheral adrenal steroidogenesis. Because it lacks the full ACTH amino acid sequence required for adrenocortical receptor activation, Semax operates independently of the hypothalamic-pituitary-adrenal (HPA) axis.

In chemical literature, Semax is classified as a regulatory neuropeptide. Physical specifications typically report a molecular weight of 810.92 g/mol and high solubility in aqueous buffer solutions. To ensure baseline uniformity across neurochemical assays, laboratories source synthetic batches manufactured under rigid solid-phase peptide synthesis (SPPS) conditions, available via the PX1 Research peptide catalog.

How does Semax work? Key biological mechanisms

Preclinical investigations demonstrate that Semax influences multiple neurochemical pathways simultaneously. The predominant mechanism identified in neurodevelopmental and ischemic animal models is the rapid transcription and release of neurotrophins, specifically brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF).

Through upregulation of BDNF and its primary receptor TrkB, Semax exposure is associated with increased synaptic plasticity, neuronal survival, and dendritic spine density in rodent hippocampal formations. Additionally, gene expression profiling shows that Semax modulates transcript levels of melanocortin receptors (MC4 and MC5) in rat forebrain tissue.

Beyond neurotrophic signaling, Semax influences monoaminergic pathways by modulating dopamine and serotonin turnover rates in the striatum and hypothalamus. Furthermore, in vitro biochemical assays indicate that Semax acts as a competitive inhibitor of enkephalin-degrading enzymes, thereby prolonging the endogenous stability of native opioid neuropeptides. Researchers studying complementary central signaling mechanisms frequently evaluate Selank research peptides alongside Semax to compare distinct neuropeptide pathways.

Preclinical findings: BDNF induction and neuroprotection

In animal models of focal cerebral ischemia, Semax administration has been shown to reduce infarct volume and attenuate neurological deficits. Transcriptomic studies reveal that within three hours of administration, Semax alters the expression of over 100 genes linked to vascular growth, inflammatory cascades, and cell survival in rat cortical tissue.

The neuroprotective capacity of Semax is heavily tied to its impact on inflammatory signaling pathways. Preclinical models of brain injury demonstrate a down-regulation of pro-inflammatory cytokines—including interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α)—alongside an upregulation of anti-inflammatory markers.

In cognitive performance models, rodents exposed to Semax exhibit enhanced spatial memory acquisition and passive avoidance retention. These findings correlate with elevated hippocampal BDNF protein concentrations, reinforcing the hypothesis that Semax acts primarily as a neurotrophin-inducing neuropeptide. Detailed experimental parameters can be reviewed in our neuroscience research paper database.

Reconstitution, storage, and laboratory administration

Lyophilized Semax should be stored at -20°C prior to reconstitution to maintain molecular integrity over extended periods. Upon receipt, scientific personnel should allow the vial to reach room temperature before adding reconstitution diluents to prevent condensation moisture from degrading the cake structure.

For parenteral or in vitro research applications, sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4) is recommended. When preparing liquid solutions intended for intranasal administration models, researchers utilize sterile saline or specialized nasal delivery buffers. Gently swirl the vial until dissolved; mechanical vortexing should be avoided as shear forces can disrupt delicate peptide bonds.

Reconstituted Semax solutions remain stable at 2°C to 8°C for approximately 30 days. For long-term analytical series, aliquoting reconstituted solutions into single-use microcentrifuge tubes and freezing at -80°C minimizes freeze-thaw degradation cycles. Qualified laboratories can buy research-grade Semax vials designed specifically for precise scientific volumetric measurements.

Comparing Semax analogs: Semax vs. Selank vs. N-Acetyl Semax Amidate

When designing neurochemical experiments, investigators frequently compare original Semax against modified derivatives and alternative regulatory peptides. Understanding the functional differences between these compounds allows researchers to select the optimal peptide candidate for specific receptor targets.

N-Acetyl Semax Amidate features an N-terminal acetylation and C-terminal amidation. These chemical modifications increase lipophilicity and resistance to enzymatic degradation, yielding enhanced BBB permeability in rodent models relative to parent Semax. Conversely, Selank research peptides represent a synthetic heptapeptide derived from tuftsin, targeting GABAergic signaling rather than ACTH/melanocortin pathways.

Another regulatory peptide frequently studied in cellular longevity models alongside Semax is Epitalon, which operates via telomerase upregulation rather than direct neurotrophic factor induction. Evaluating these distinct biochemical profiles provides comprehensive insights into synthetic neuropeptide kinetics.

Evaluating Semax purity: HPLC, MS, and endotoxin verification

In analytical peptide chemistry, high-performance liquid chromatography (HPLC) establishes chemical purity by measuring the relative area of the target peptide peak against synthesis impurities or breakdown products. A standard research threshold requires ≥98% purity to prevent non-specific cellular reactions.

Mass spectrometry (MS) confirms molecular identity by determining the exact mass-to-charge ratio (m/z) of the synthesized peptide, confirming correct amino acid sequence assembly. For Semax (810.92 g/mol), MS analysis confirms the absence of truncated sequences or incomplete deprotection products.

Endotoxin testing via Limulus Amebocyte Lysate (LAL) assays is critical for cell culture and in vivo animal models. Bacterial endotoxins (lipopolysaccharides) induce severe inflammatory responses that confound neurochemical data. PX1 Research enforces strict lot-specific endotoxin thresholds (<0.01 EU/mg) across all batches, ensuring clean experimental baselines when you order Semax for laboratory research.

PX1 Research vs. standard vendor criteria

Selecting an institutional supplier requires systematic evaluation of chemical quality controls, analytical transparency, and domestic fulfillment logistics. Below is an overview of how PX1 Research criteria align with laboratory procurement standards:

Purity Verification: PX1 Research conducts independent third-party HPLC testing on every individual manufacturing lot, verifying ≥98% pure peptide content. Generic vendors often rely on single-batch factory COAs.

Mass Identity & Endotoxin Control: PX1 Research provides mass spectrometry sequence verification and quantitative LAL endotoxin testing per lot (<0.01 EU/mg). Standard vendors rarely perform endotoxin assays.

Sourcing & Traceability: PX1 Research enforces domestic US synthesis protocols with transparent batch tracking from synthesis to delivery. Many online suppliers distribute unverified overseas imports.

Fulfillment & Support: PX1 Research dispatches orders same-day (M–F before 3 PM EST) from dual fulfillment centers in Arizona and California, backed by PhD-level technical support. Generic suppliers frequently experience extended international transit times and minimal technical documentation.

Red flags when sourcing Semax for research

Procuring research peptides requires vigilance regarding vendor credentials. A primary red flag is the absence of downloadable, lot-specific Certificate of Analysis (COA) documents verified by an independent US testing laboratory. Static, unverified images or non-lot-specific COAs suggest inadequate quality control.

Avoid suppliers making clinical, therapeutic, or human dosing claims. Semax is strictly designated for laboratory research use only. Vendors advertising pre-mixed, unbuffered human administration kits operate outside proper scientific regulatory frameworks and risk biological contamination.

Additionally, beware of vendors who fail to provide mass spectrometry data alongside HPLC chromatograms. HPLC alone verifies purity percentage but cannot definitively confirm molecular weight or sequence correctness. To review verified technical documentation, visit our full peptide research catalog.

Ordering Semax from PX1 Research

PX1 Research provides certified, high-purity Semax supplied as lyophilized powder in sealed 10 mg glass research vials. Each batch undergoes rigorous third-party analytical testing to confirm purity, identity, and endotoxin compliance prior to inventory release.

Orders placed before 3:00 PM EST Monday through Friday ship same-day from our strategically located fulfillment hubs in California and Arizona. Shipments are packed in protective thermal packaging with full domestic tracking to ensure safe delivery to your laboratory facility.

Every shipment includes direct access to lot-specific COAs, mass spectra, and HPLC chromatograms. For institutional purchasing, volume discounts, or custom synthesis requirements, research teams can contact our technical support staff or request quotes through our bulk peptide procurement page. Ready to advance your experimental protocols? Buy Semax research vials today.